Factor V Leiden Test at Ayzal Lab

Factor V (Leiden Factor) at Ayzal Lab

The Factor V Leiden mutation test is a specialized molecular genetic analysis used to identify a specific genetic mutation in the F5 gene. This mutation leads to a variant of human factor V protein that cannot be easily inactivated by activated protein C (APC), a natural anticoagulant. Consequently, individuals carrying this mutation have a significantly increased predisposition to developing abnormal blood clots, a clinical state known as thrombophilia. Ayzal Lab, a premier diagnostic facility in Lahore, Pakistan, offers this advanced molecular assay to assist clinicians in evaluating patients with unexplained thrombotic events, recurrent miscarriages, or a strong family history of venous thromboembolism (VTE).

Understanding your genetic predisposition to blood clotting is essential for long-term health management. The Factor V Leiden mutation is the most common inherited risk factor for hereditary thrombophilia. Under normal physiological conditions, Factor V plays a critical role in the coagulation cascade, facilitating the generation of thrombin, which forms blood clots to stop bleeding. However, when the Leiden mutation is present, the altered Factor V molecule resists cleavage by activated protein C. This resistance allows the coagulation process to continue longer than necessary, increasing the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). At Ayzal Lab in Lahore, we utilize state-of-the-art polymerase chain reaction (PCR) technology to detect this mutation with high sensitivity and specificity, providing patients and physicians with definitive diagnostic clarity.

Clinical Importance and Diagnostic Value

The diagnostic value of the Factor V Leiden test lies in its ability to confirm or rule out an inherited genetic cause for hypercoagulability. Identifying this mutation allows hematologists, obstetricians, and primary care physicians to design personalized preventive strategies, especially during high-risk periods such as pregnancy, major surgery, prolonged immobilization, or when considering oral contraceptives. Knowing a patient’s genetic status helps prevent life-threatening thromboembolic events through targeted prophylactic anticoagulation therapy. Furthermore, because this is an inherited autosomal dominant trait, positive results can provide vital health insights for immediate family members who may also carry the mutation unknowingly.

Clinical Procedure: What to Expect

Patient Preparation

To ensure accurate results and a seamless testing experience at Ayzal Lab, patients should follow these preparation guidelines:

• No Fasting Required: Unlike routine biochemistry profiles, the Factor V Leiden genetic test does not require fasting. You may eat and drink normally prior to your appointment.
• Medication Disclosure: Inform the laboratory staff and your physician about all medications you are currently taking, especially anticoagulants (such as warfarin, heparin, or direct oral anticoagulants) and antiplatelet drugs. While these medications do not alter your genetic DNA sequence, they are critical for the clinical interpretation of your overall coagulation profile.
• Hydration: Drink plenty of water before the test, as proper hydration makes venipuncture easier by keeping your veins well-filled.
• Identification and Documentation: Bring your physician’s referral slip and a valid government-issued identification card for accurate patient registration.

During the Procedure

The Factor V Leiden test is a straightforward laboratory investigation involving a standard venipuncture. When you arrive at Ayzal Lab, you will be guided to a comfortable blood collection room. A certified phlebotomist will verify your identity and explain the procedure. The phlebotomist will locate a suitable vein, typically in the inner bend of your elbow, and cleanse the area with an antiseptic swab to prevent infection. A sterile, single-use needle will be inserted into the vein to draw a small sample of blood into a lavender-top tube containing ethylenediaminetetraacetic acid (EDTA), which prevents the blood from clotting and preserves the white blood cells containing your DNA. The needle is then gently removed, and a small bandage is applied to the puncture site. The entire collection process takes less than five minutes and involves minimal discomfort, comparable to a mild pinch.

When is a Factor V (Leiden Factor) Test Performed?

Unexplained Deep Vein Thrombosis (DVT)

Physicians frequently order the Factor V Leiden test when a patient experiences a deep vein thrombosis without an obvious provoking factor, such as major trauma or surgery. DVT typically presents as unilateral leg pain, swelling, warmth, and redness. Identifying the mutation helps clinicians determine the appropriate duration of anticoagulant therapy to prevent recurrent clots.

Pulmonary Embolism (PE)

A pulmonary embolism is a life-threatening condition where a blood clot travels to the lungs, causing sudden shortness of breath, sharp chest pain, and a rapid heart rate. When a PE occurs in a young individual or without a clear trigger, a Factor V Leiden test is indicated to evaluate for underlying hereditary thrombophilia, guiding long-term preventive care.

Recurrent Pregnancy Loss

Recurrent miscarriages, particularly those occurring in the second or third trimester, or unexplained stillbirths can be linked to placental thrombosis caused by maternal hypercoagulability. Obstetricians request this genetic test to identify if Factor V Leiden is contributing to placental insufficiency, allowing for targeted therapy in subsequent pregnancies.

Strong Family History of Thrombosis

If an individual has a first-degree relative (parent, sibling, or child) diagnosed with a Factor V Leiden mutation or a history of early-onset venous thromboembolism (before age 50), testing is highly recommended. This proactive screening helps asymptomatic carriers take necessary precautions during high-risk situations like long-haul travel or surgery.

Thrombosis in Unusual Anatomical Sites

Developing a blood clot in atypical locations—such as the portal vein, hepatic vein (Budd-Chiari syndrome), mesenteric veins, or cerebral venous sinuses—is a strong clinical indicator for inherited thrombophilia. The Factor V Leiden test helps pinpoint the genetic etiology behind these complex and rare clinical presentations.

What Does a Factor V (Leiden Factor) Detect?

The Factor V Leiden molecular test is designed to detect the presence or absence of the specific G1691A mutation (also known as the R506Q mutation) in the Factor V gene. The analysis determines three possible genetic states:

• Wild Type (Normal / Negative): No mutation is detected. The patient has two normal copies of the Factor V gene, indicating no inherited risk for Factor V Leiden-associated thrombophilia.
• Heterozygous Mutation (Positive – One Copy): The patient has one mutated copy and one normal copy of the gene. This state increases the risk of developing a blood clot by approximately 3 to 8 times compared to the general population.
• Homozygous Mutation (Positive – Two Copies): The patient has inherited two copies of the mutated gene (one from each parent). This rare condition significantly elevates the lifetime risk of venous thromboembolism, up to 50 to 80 times the normal risk.
• Activated Protein C (APC) Resistance: The test confirms the genetic basis for resistance to the anticoagulant action of activated protein C, explaining the physiological mechanism behind the patient’s hypercoagulable state.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that waiting for genetic test results can be stressful. Because the Factor V Leiden test involves complex molecular diagnostics and DNA amplification, the processing time is longer than routine blood tests. Typically, results are finalized within 3 to 5 working days. Ayzal Lab utilizes advanced laboratory information management systems to ensure maximum accuracy and security. Once your report is signed off by our consultant pathologist, you will receive an automated SMS notification. Reports can be conveniently accessed and downloaded online via the official Ayzal Lab web portal or collected in person at our Lahore facility.

Factor V (Leiden Factor) Findings Overview

The following table outlines the parameters evaluated during the Factor V Leiden genetic analysis and their clinical interpretation:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Factor V Gene Mutation (G1691A)	Negative (Wild Type / No mutation detected)	Heterozygous (One mutated allele) or Homozygous (Two mutated alleles)
Activated Protein C (APC) Sensitivity	Normal sensitivity to APC (Normal clotting time prolongation)	APC Resistance (Diminished response to APC, indicating hypercoagulability)
Thrombotic Risk Level	Baseline population risk	Mildly to moderately elevated (Heterozygous) or severely elevated (Homozygous) risk
Inheritance Pattern	Not applicable	Autosomal dominant transmission risk to offspring

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Factor V (Leiden Factor)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, molecular biologists, and technologists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality at every step of the diagnostic journey.
• Quality Diagnostic Services: Ayzal Lab adheres to strict internal and external quality control protocols to ensure highly reproducible and accurate results.
• Professional Reporting: Our reports are comprehensive, easy to understand, and structured to provide clear clinical guidance to your referring physician.
• Modern Diagnostic Approach: We utilize advanced molecular diagnostic platforms and state-of-the-art PCR technology for genetic testing.
• Comfortable Environment: Our Lahore collection center is designed to provide a clean, hygienic, and welcoming atmosphere for all patients.
• Convenient Location: Easily accessible within Lahore, making it simple for patients to visit for sample collection.
• Commitment to Accurate Diagnosis: We are dedicated to delivering precise diagnostic insights that empower clinicians to make informed treatment decisions.